Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 1 4 Phase 4 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 410 Cyclophosphamide 394 Carboplatin 306 Gemcitabine 286 Nivolumab 276 Paclitaxel 274 Cisplatin 252 Radiotherapy 225 Dexamethasone 210 Bevacizumab 209 fludarabine 192 Docetaxel 187 Rituximab 183 Capecitabine 171 Oxaliplatin 158 Lenalidomide 157 Fluorouracil 152 Temozolomide 138 Cytarabine 135 Etoposide 128 Irinotecan 124 Cetuximab 123 fludarabine phosphate 120 Injections 118 venetoclax 116 Ipilimumab 115 Doxorubicin 114 Azacitidine 108 130-nm albumin-bound paclitaxel 108 Pemetrexed 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × relmacabtagene autoleucel × Clear all

NCT05370547 2024-03-06

Chidamide Bridging for CAR-T Therapy

Chinese PLA General Hospital

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡